Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy

Journal of the American College of Cardiology

Volumn 45, Issue 6, 2005, Pages 855-857

  Duboc, Denis ^a,c   Meune, Christophe ^a   Lerebours, Guy ^b   Devaux, Jean Yves ^a   Vaksmann, Guy ^a   Bécane, Henri Marc ^a  

^a Fr Working Grp Heart I   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c Cochin Hospital ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INOTROPIC AGENT; PERINDOPRIL; PLACEBO; TECHNETIUM 99M;

ADOLESCENT; ARTICLE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DUCHENNE MUSCULAR DYSTROPHY; FEVER; HEADACHE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYOCARDIAL DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCHOOL CHILD; SIDE EFFECT; WEIGHT REDUCTION;

EID: 14844318046     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.09.078     Document Type: Article

References (10)

1. Emery AEH. Duchenne muscular dystrophy or Meryon's disease. In: The Muscular Dystrophies. 2nd edition. Oxford: Oxford University Press, 1993:55-71.
2. P. Melacini, A. Vianello, C. Villanova Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy Neuromuscular Disord 6 1996 367 376
3. G. Nigro, L.I. Comi, L. Politano, R.J. Bain The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy Int J Cardiol 26 1990 271 277
4. M. Mukoyama, K. Kondo, K. Hizawa, H. Nishitani Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan J Neurol Sci 81 1987 155 158
5. R. Garg, S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitor on mortality and morbidity in patients with heart failure Collaborative Group on ACE Inhibitor Trials JAMA 273 1995 1450 1456
6. T. Ryoke, Y. Gu, L. Mao Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition Circulation 100 1999 1734 1743
7. S.J. Haleen, R.E. Weishaar, R.W. Overhiser Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster Hemodynamic, morphological, and biochemical correlates Circ Res 68 1991 1302 1312
8. H. Greenberg, P. McMaster, E.M. Dwyer Jr Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study J Am Coll Cardiol 4 1984 867 874
9. G. Corrado, A. Lissoni, S. Beretta Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy Am J Cardiol 89 2002 838 841
10. C. Meune, O. Pascal, H.M. Bécane Reliable detection of early myocardial dysfunction by tissue Doppler echocardiography in Becker's muscular dystrophy Heart 90 2004 947 948